DongKoo Bio & Pharma Co., Ltd. (KOSDAQ: 006620)
South Korea flag South Korea · Delayed Price · Currency is KRW
5,820.00
+80.00 (1.39%)
Oct 11, 2024, 9:00 AM KST

DongKoo Bio & Pharma Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2017 2016 - 2015
Period Ending
Oct '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '17 2016 - 2015
Market Capitalization
158,897156,349169,609232,556240,580-
Upgrade
Market Cap Growth
19.22%-7.82%-27.07%-3.34%--
Upgrade
Enterprise Value
204,926172,036175,056221,869244,593-
Upgrade
Last Close Price
5820.005660.006009.597906.487931.13-
Upgrade
PE Ratio
12.3313.2425.2223.9624.55-
Upgrade
PS Ratio
0.670.720.871.501.73-
Upgrade
PB Ratio
1.411.421.662.322.54-
Upgrade
P/FCF Ratio
-12.19-15.2414.3217.05108.33-
Upgrade
P/OCF Ratio
16.0243.6110.0812.9932.13-
Upgrade
EV/Sales Ratio
0.850.800.901.431.76-
Upgrade
EV/EBITDA Ratio
10.458.337.7916.8220.19-
Upgrade
EV/EBIT Ratio
15.3511.7710.4027.2632.13-
Upgrade
EV/FCF Ratio
-13.26-16.7714.7816.27110.14-
Upgrade
Debt / Equity Ratio
0.620.400.340.240.250.40
Upgrade
Debt / EBITDA Ratio
3.522.121.531.841.960.97
Upgrade
Debt / FCF Ratio
-4.49-4.272.901.7810.691.73
Upgrade
Asset Turnover
1.191.191.191.04-1.44
Upgrade
Inventory Turnover
2.362.262.742.52-3.54
Upgrade
Quick Ratio
0.470.600.830.971.160.93
Upgrade
Current Ratio
0.931.211.321.481.791.29
Upgrade
Return on Equity (ROE)
11.94%11.11%6.54%9.58%-35.35%
Upgrade
Return on Assets (ROA)
4.17%5.03%6.44%3.40%-11.83%
Upgrade
Return on Capital (ROIC)
5.20%6.29%8.07%4.19%-17.28%
Upgrade
Earnings Yield
8.11%7.55%3.90%4.01%3.80%-
Upgrade
FCF Yield
-9.72%-6.56%6.98%5.86%0.92%-
Upgrade
Dividend Yield
2.06%2.12%----
Upgrade
Payout Ratio
25.47%25.72%42.39%10.11%10.32%-
Upgrade
Buyback Yield / Dilution
0.44%0.48%1.78%0.12%-25.96%20.35%
Upgrade
Total Shareholder Return
2.50%2.60%1.78%0.12%-25.96%20.35%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.